The history of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial introduction generated massive profits, the lapse of its patent opened the avenue to off-brand competitors, https://ezmarkbookmarks.com/story21765982/the-copyright-and-big-pharma-a-risky-bet